Abstract Autism spectrum disorder is a complex neurodevelopmental disorder whose pathophysiology remains elusive as a consequence of the unavailability for study of patient brain neurons; this deficit may potentially be circumvented by neuraldifferentiationofinduced pluripotent stem cells. Rare syndromes with single gene mutations and autistic symptoms have significantly advanced the molecular and cellular understanding of autism spectrum disorders; however, in aggregate, they only represent a fraction of all cases of autism. In an effort to define the cellular and molecular phenotypes in human neurons of non-syndromic autism, we generated induced pluripotent stem cells (iPSCs) from three male autism spectrum disorder patients who had no identifiableclinicalsyndromes,andtheirunaffectedmalesiblings and subsequently differentiated these patient-specific stem cells into electrophysiologically active neurons. iPSCderived neurons from these autistic patients displayed decreases in the frequency and kinetics of spontaneous excitatory postsynaptic currents relative to controls, as well as significant decreases in Na + and inactivating K + voltage-gated currents. Moreover, whole-genome microarray analysis of gene expression identified 161 unique genes that were significantly differentially expressed in autistic patient iPSC-derived neurons (>twofold, FDR < 0.05). These genes were significantly enriched for processes related to synaptic transmission, such as neuroactive ligand-receptor signaling and extracellular matrix interactions, and were enriched for genes previously associated with autism spectrum disorder. Our data demonstrate aberrant voltage-gated currents and underlying molecular changes related to synaptic function in iPSCderived neurons from individuals with idiopathic autism as compared to unaffected siblings controls.
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Introduction
Autism spectrum disorder (ASD) is a heterogeneous group of disorders with a prevalence of one in 60 to 70 children [1] .
This grouping of ASD is characterized by core symptoms of behavioral deficits and extended phenotypes (associated clinical features). The core symptoms, which vary in severity, include persistent behavioral deficits in social interaction and communication, repetitive behaviors, and restricted social interests. Autism is called a Bspectrum disorder^because of the extraordinary heterogeneity of the severity of core symptoms, the extended phenotypes, and possibly their divergent etiology [2] . Extended ASD phenotypes include seizures, intellectual disability, speech and other developmental delays, dysmorphic features, cardiac arrhythmias, skin manifestations, hematoma, comorbidity diseases, male preponderance, gene associations, and other manifestations. ASD is comorbid with a number of other diseases, including tuberous sclerosis, Fragile X syndrome, Timothy syndrome, male Rett syndrome (with MECP2 gene mutation), and chromosomal abnormalities syndromes (Angelman, Prader-Willi, Phelan-McDermid, and other syndromes). ASD is skewed towards boys, with a sex ratio of at least 2.7 to 1 [3] . Large population genomewide association studies (GWAS) [4] , de novo mutations [5] , and copy number variation (CNV) [6] studies have identified hundreds of genes and genomic regions significantly associated with ASD [7] . To date, more than 500 genes and 44 genomic loci have been associated with the symptom/ syndrome complex of ASD [8] . Though there is a strong genetic basis for ASD, the majority of cases have unknown causes. Identifiable single gene disorders such as tuberous sclerosis have been identified in 10 % of ASD individuals; known chromosomal abnormalities such as 22q13.3 deletion have been identified in 5-10 % of cases [9] . However, none of these etiologies alone account for more than 2 % of cases [7] . The common feature of all these syndromes, together with extended phenotypes, is dysfunctional socialization and communication, and stereotyped and repetitive behavior. Brain imaging studies have failed to identify consistent anatomic abnormalities that are unique to Bautism^though they are useful diagnostic adjuncts. The unifying feature that has emerged from functional magnetic resonance imaging is that the brain exhibits Baltered connectivity, specifically increased local short-distance connectivity, and decreased long-distant connectivity^ [10, 11] . A central hypothesis that has been proposed is altered synaptic transmission [12] . However, the paucity of patient brain tissue and genetic heterogeneity make it difficult to explore the molecular and cellular pathophysiology of ASD. This deficit may be circumvented through the use of neural differentiation of induced pluripotent stem cells (iPSCs) [13] . Patient-specific iPSCs maintain the genetic background of parental cells, a feature critically important for the study of disorders with complex genetics such as ASD [14] . Our postulation is that multiple genetic mutations give rise to dysfunctional transcription and/or translation which, at different times in brain development or in different regions of the brain, give rise to the socialization and communication deficits that are part of multiple syndromes accounting for ASD. We also postulate that iPSC-derived neurons from ASD individuals will exhibit altered synaptic transmission (cultured cell phenotype), and that altered gene expression will mimic or reflect many of the gene associations that have been characterized from genetic studies of ASD.
In this small preliminary study, we studied a relatively clinically homogeneous patient population with idiopathic forms of ASD and distinguished them from patients with known genetic disease or a recognizable syndrome. We excluded patients with severe intellectual disability, primary seizure disorders, or known syndromes or malformations. In addition, relative homogeneity of these patients was also based on all male sex, age ranges (5-16 years), no dysmorphic findings, nor other neurologic deficits. We also studied unaffected male siblings of these patients as controls. We derived iPSCs from skin fibroblasts from ASD patients and their unaffected male siblings, and differentiated them into mature cortical-like neurons. Comparison of autistic patient and control iPSC-derived neurons by morphological (synaptic density), electrophysiological (whole-cell patch clamp recordings), and transcriptional analyses (global transcriptome analysis) showed aberrant cellular and molecular phenotypes in synaptic transmission and voltage-gated ion channels. Substantially greater numbers of patient-specific iPSC-derived neurons must be generated in future investigation of larger cohorts to validate this preliminary study.
Materials and Methods
Additional details are provided in the Supplementary material 1 section.
Experimental Design
We studied a clinically homogeneous cohort of male patients with idiopathic forms of ASD and did not have severe intellectual disability, primary seizure disorders, or known syndromes or malformations (Fig. 1a) . Skin fibroblasts were obtained from three male patients with ASD and their unaffected neurologically normal age-matched male siblings, as well as two age-and sex-matched unrelated healthy donors. Characteristics of patients and sib controls are described in Table 1 and Supplementary file 1: Table S1 . We first optimized protocols including iPSC generation from skin fibroblasts (Supplementary file 1: Fig. S1A ) and neural differentiation from iPSCs (Supplementary file 1: Fig. S5A and Fig. 2a ). We performed extensive quality control analyses (pluripotency characterization, karyotyping) to select iPSC Fig. 1 Experimental scheme of applying iPSC methodology for development of a cellular model in a clinically homogeneous subset of patients with ASD. a We studied a clinically homogeneous patient population of boys with idiopathic forms of ASD (Bintrinsic autism^) by excluding patients with known genetic disease or recognizable syndromes, as well as exclusion of those with severe intellectual disability or primary seizure disorders. b To assess the neural cellular and molecular phenotypes of ASD, we created iPSCs from skin fibroblasts from autistic boys and their unaffected male siblings and then differentiated these iPSCs into electrophysiologically active neurons. Assays for gene expression, neurite outgrowth, synaptic density, and electrophysiology were used to compare autistic patient and control iPSC-derived neurons. See also Table 1, Supplementary file  1: Table S2 for patient and cell line information lines from each donor and differentiated iPSC lines into mature cortical-like neurons, which fired action potentials and formed functional synapses. Through comparison of autistic patient and control iPSC-derived neurons, we investigated the cellular phenotypes of ASD in vitro from three aspects: morphological (synaptic density), electrophysiological (wholecell patch clamp recordings), and transcriptional analyses (global transcriptome analysis) (Fig. 1a) .
Recruitment of Patients with Idiopathic Form of ASD
Participants with idiopathic forms of ASD were recruited from ongoing research studies in the NIH Clinical Center Genetic Clinic. Additionally, the unaffected, neurologically normal age-and sex-matched siblings of these patients, as well as age-and sex-matched unrelated healthy donors were also recruited as controls. All participants or their 
Generation and Characterization of iPSC
Generation, maintenance, and characterizations of iPSCs were performed as described elsewhere [19] , with specific modifications described in the Supplementary material 1. iPSCs and hESC were cultured on MEF feeders in iPSC medium (Knockout DMEM; Life Technologies), containing 20 % Knockout SR (Life Technologies), 1 % GlutaMAX, 0.1 mM β-mercaptoethanol (Life Technologies), 1 % antibiotics, 1 % NEAA, and 10 ng/ml basic fibroblast growth factor (bFGF) (Peprotech). For characterization procedures of iPSCs, see Supplementary material 1.
Neural Induction and Differentiation from iPSCs
Neural Induction
Neural progenitor cells (NPCs) differentiation from iPSCs was induced through embryoid bodies (EBs) formation as 
Post-mitotic Neural Differentiation
To further differentiate into post-mitotic neurons, NPCs were plated onto poly-D-lysine (PDL) (Sigma) and laminin (Sigma) double-coated German glass coverslips (Neuvitro) (10, 000 cells/cm 2 ) overnight in NPC media [0.5 % N2 (Life Technologies), 1 % B27 (without Retinoic acid) (Life Technologies), 1 % GlutaMAX, 1 % NEAA, EGF (20 ng/ ml) (Peprotech), and bFGF (20 ng/ml) in DMEM/F12 medium (Life Technologies)]. On day 2, neural differentiation was induced by withdrawing EGF and bFGF and switching to neural differentiation medium consisting 1 % N2, 2 % B27 (without retinoic acid), 1 % GlutaMAX, 1 % antibiotics, BDNF (10 ng/ml), GDNF (10 ng/ml), IGF-1 (10 ng/ml), and cyclic adenosine monophosphate (cAMP) (1 μM; Sigma) in neurobasal medium (Life Technologies) (all neurotrophic factors were from Peprotech). Cells were fed every other day by removing one half the volume of medium and replacing the medium with fresh warmed medium pre-equilibrated with 95 % O 2 and 5 % CO 2 at 37°C. iPSC-derived neurons were differentiated for 2-3 months. For characterization procedures of neural rosettes, NPCs, and post-mitotic neurons, see Supplementary material 1. 
Immunofluorescent Staining and Confocal Microscopy
Cells were grown on glass cover slides. Following washing with ice-cold phosphate buffered saline (PBS), the cells were fixed in 4 % paraformaldehyde (w/v) in PBS at 4°C for 10 min. Cells were then permeabilized at room temperature for 15 min in 0.1 % Triton in PBS. Cells were blocked in 5 % goat or donkey serum with 0.1 % Triton at room temperature for 30 min. Cells were incubated with primary antibodies for overnight at 4°C, followed by 30 min to 1 h of incubation with species-specific Alexa-dye conjugates secondary antibodies from Life Technologies. Primary and secondary antibodies, and their working dilutions are described in the Supplementary material 1. The cells were thoroughly washed with PBS and examined by a Zeiss Axiovert-200 fluorescence microscope, and images were acquired using AxioVision 3.8 software (Carl Zeiss). For confocal analysis, the samples were examined with a Zeiss LSM 510 confocal microscope.
Neurite Analysis, Synaptic-Associated Marker Expression and Flow Cytometry
See Supplementary material 1 for the description of the procedure.
Electrophysiology
Whole-cell patch clamp recordings were obtained from iPSCderived neurons at 8-12 weeks after neuronal differentiation induction. For detailed description of current clamp, voltage clamp, solutions, drugs, data acquisition, analysis, and statistics, see Supplementary material 1.
Statistical Analysis of Cellular Studies
For neuronal morphology and flow cytometry experiments, all comparisons between autistic patient and control samples were tested by unpaired, two-tailed Student's t test. A p value <0.05 was considered significantly different.
For electrophysiology experiments, pooled data are presented as either mean ± SEM or box plots and statistical analyses were performed using Mann-Whitney U test. p values are reported in the text or figures with values <0.05 considered as significant (*p < 0.05).
RT-PCR, Microarray Analysis, and Bioinformatics Analysis
Quantitative Real-Time RT-PCR For detailed description of quantitative PCR, and primers used for PCR amplification of selected genes, see Supplementary material 1.
Microarray Analysis
Whole-genome expression profiles were assessed with Affymetrix GeneChip® Human Gene 1.0 ST Array (Affymetrix). See Supplementary material 1 for detailed description of microarray procedures. To analyze differentially expressed genes, we first removed batch effects and then compared the difference of the mean expression for each gene by Student's t test. We clustered the iPSC-derived neuron samples based on the differentially expressed gene sets. Genes with fold change >2 or <−2 and a false discovery rate (FDR) p value <0.05 were considered significant.
GO Categories
To assess for functional categories that the genes we identified as significantly differentially expressed in ASD implicated, we used the Database for Annotation, Visualization and Integrated Discovery v6.7, accessed at http://david.abcc.ncifcrf.gov. GO categories were reported as significant only if the p value after multiple testing corrections was <0.05.
Integrated Gene-Network Analysis
Integrated gene-network analysis was generated using Ingenuity Pathways Analysis (version 8.8; Ingenuity® Systems, www.ingenuity.com). See Supplementary material 1 for procedures of analysis. Functional network analysis identified the biological interactions that were most significant to the molecules in the network. A p value of less than 0.05 was considered significant. The network molecules associated with biological functions and/or diseases in Ingenuity's Knowledge Base were considered for the analysis. Right-tailed Fisher's exact test was used to calculate a p value determining the probability that each biological function assigned to that network is due to chance alone, with a threshold of 0.05 set for significance.
Autworks Gene-Disorder Analysis
The overlap of the identified differentially expressed genes with other neurodevelopmental disorders was assessed using the Autworks Gene-Disorder Analysis software, accessed at http://autworks.hms.harvard.edu/. Default parameters were used throughout the analysis.
Accession Number
Microarray data were deposited in the National Center for Biotechnology Information Gene Expression Omnibus database under the accession ID GSE65106.
Results
Patient Recruitment and Derivation of iPSC Lines
Participants with idiopathic forms of ASD and their unaffected healthy siblings, as well as age-and sex-matched unrelated healthy donors were recruited from ongoing research studies in the NIH Clinical Center Genetic Clinic. As shown in Fig. 1a and Table 1 , the autistic patients we studied in this small preliminary study, none of them have a recognizable syndrome associated with ASD (based on assessment by geneticists), have been shown by molecular studies not to have disorders such as Fragile X, Rett (atypical) syndrome, tuberous sclerosis, neurofibromatosis type 1, and other identifiable syndromes. These patients have had array studies (CGH) which were non-diagnostic, but have not had whole exome sequencing. Imaging studies (MRI) were non-diagnostic. In addition, relative homogeneity of these patients was based on all male sex, age ranges from 5 to 16 years, no dysmorphic findings, moderate intellectual disability, no history of seizures, nor other neurologic deficits (Table 1) . Skin fibroblasts were obtained from three male patients with ASD and their unaffected male siblings. The participants AA1, AA2, and AA3 in this study met criteria for ASD based on the ADI-R [18] and the ADOS-G [15] assessment, and were given a diagnosis of ASD after an additional thorough clinical assessment by pediatricians and neurologists in the NIH Clinical Center Genetic Clinic. Characteristics of patients and sib controls are described in Table 1 .
To generate iPSC lines, patient and control fibroblasts were infected with polycistronic lentivirus expressing human OCT4, SOX2, KLF4, and c-MYC [21] , as described elsewhere [19] . Round and flattened reprogrammed colonies emerged from a background of fibroblasts 2 weeks after infection (Supplementary file 1: Fig. S1 ). Reprogrammed colonies with similar morphology to human embryonic stem cells (hESCs) and positive for TRA-1-60 (a surface marker associated with pluripotency) immunostaining were initially selected and passaged manually (Supplementary file 1: Fig. S1 ), and subsequently validated using immunostaining to verify expression of pluripotency markers.
We performed extensive quality control analyses to select iPSC lines from each donor. Similar to hESC lines ESI-053 and CT-2, these selected patient-specific iPSC lines showed hESCs colony morphology and positive expression of pluripotency markers NANOG, OCT4, SOX2 (in the nucleus), and surface markers SSEA4, TRA-1-60, and TRA-1-81 by immunostaining (Supplementary file 1: Fig. S2 ). All iPSC lines maintained a normal male karyotype throughout passaging (Supplementary file 1: Fig. S3A ). Pluripotency of iPSC was examined by teratoma formation assay in vivo. Histological analysis of the teratoma sections revealed organized structures representing tissues from three germ layers, such as gland and duct structure from endoderm, bone and white adipocytes from mesoderm, and neural rosettes and pigmented neural cells from ectoderm (Supplementary file 1: Fig. S3B) . Additionally, microarray analysis indicated iPSC global gene expression was similar to hESCs, but distinct from their parental fibroblast cells (Supplementary file 1: Fig. S4 ). Based on demonstration of normal karyotypes, pluripotent marker expression, capability to generate three germ layers in vivo, and global expression profiles similar to hESCs, iPSC lines were selected for neural differentiation and cellular and molecular characterization ( Fig. 1b; see Supplementary file 1: Table S1 list of cell lines used).
Autistic Patient iPSCs Can Be Differentiated into Functional and Electrophysiological Active Neurons In Vitro
We differentiated iPSCs into neural progenitors and neurons using conditions favoring generation of cortical neurons (Fig. 2a) [22] [23] [24] [25] . Neural progenitor cells (NPCs) differentiated from iPSCs through embryoid body intermediates exhibited neural progenitor markers SOX1 and NESTIN (Supplementary file 1: Fig. S5 ). NPCs were differentiated into post-mitotic neurons by withdrawing growth factors bFGF and EGF. Cells were cultured in the presence of BDNF, GDNF, IGF, ascorbic acid, and cAMP for more than 8 weeks to promote terminal differentiation (Fig. 2a, b) .
Differentiated neurons expressed pan-neuronal markers Tuj1 and MAP2 (Fig. 2c) . In addition, we observed glial lineage cells, such as GFAP-positive astrocytes and A2B5-positive type 2 astrocytes (Fig. 2c ). There were approximately 82 % MAP2-positive neuronal cells and 15 % GFAP-positive glial cells in the culture (Fig. 2d) . Further characterization of the neurons showed that the majority (∼70 %) of MAP2-positive neurons were glutamate-positive glutamatergic neurons, and approximately 30 % of the neurons were GABAergic neurons, while less than 5 % were dopaminergic neurons (Fig. 2e) .
iPSC-derived neurons following 80 days of post-mitotic neural differentiation expressed synaptic-associated proteins synaptophysin (SYN) along the dendritic arbors of neuron (Fig. 2f) , indicating formation of synapse and maturation of neural culture. In agreement with morphological data, wholecell patch clamp recordings showed that both autistic patient and control iPSC-derived neurons fired trains of action potentials in response to somatic current injection of 10 pA (Fig. 2h and Supplementary file 1: Fig. S6A ). Both showed Na + and K + voltage-gated currents in response to a depolarizing voltage step (Fig. 2j and Supplementary file 1: Fig. S6B ). Bath application of tetrodotoxin (TTX), a specific Na + voltagegated channel blocker, suppressed action potentials (Fig. 2i ) and Na + current (Fig. 2k) . Thus, both autistic patient and control iPSC cells differentiated into electrophysiologically active neurons. These patient-specific neurons might allow identification of cellular phenotypes and examination of the molecular basis of the disease. We next investigated morphological (synaptic density), electrophysiological (whole-cell patch clamp recordings), and transcriptional differences of iPSC-derived neurons from autism as compared to their male sib controls (Fig. 1b) .
Neurons Derived from Autistic Patient iPSCs Displayed Altered Spontaneous Excitatory Postsynaptic Currents
We studied neurite outgrowth number and synaptic-associated protein density to investigate morphological phenotypes of iPSC-derived neurons. The number of neurites was unaltered between autistic patient and control iPSC-derived neurons (Fig. 3a, b) . Figure 3c illustrates cellular location of pre-and postsynaptic proteins in excitatory and inhibitory neurons. Both autistic patient and control iPSC-derived neurons expressed pre-and postsynaptic markers, including SYN, PSD-95, vesicular glutamate transporter 1 (VGLUT1), and vesicular GABA transporter (VGAT), indicative of neuronal maturation (Fig. 3d) . Though synaptic-associated protein densities of autistic patient and control iPSC-derived neurons were not significantly different, we observed slightly decreased densities of SYN, PSD-95, VGLUT1, and VGAT puncta in autistic patient iPSC-derived neurons (Fig. 3e) .
Spontaneous inhibitory postsynaptic currents (sIPSCs) and excitatory postsynaptic currents (sEPSCs) were measured to assess intercellular connectivity and network formation [20] . Both sIPSC and sEPSC events were observed in autistic patient and control iPSC-derived neuronal cultures (Fig. 3f, g ), indicating that iPSC-derived neurons formed functional synapses and integrated into neural circuits in vitro. sEPSC analyses revealed that sEPSC frequency and half width were significantly reduced in autistic patient iPSC-derived neurons whereas amplitude and rise time remained unchanged (Fig. 3h) , most likely indicating a presynaptic defect in synaptic release [26] . These data suggest that neuronal network activity is altered in autistic patient iPSC-derived neuron cultures. These data indicate that iPSC-derived neurons show in vitro maturation of intrinsic excitability, laying the groundwork for a detailed comparison of intrinsic electrophysiological properties between ASD and controls. To examine intrinsic electrophysiological properties of iPSCderived neurons, we first analyzed the I/V curve and the input resistance, but no significant differences were observed between autistic patient and control iPSC-derived neurons (Fig. 4a, b) . Analysis of the firing phenotype of these neurons through the Input-Output function revealed that autistic patient iPSC-derived neurons reach action potential saturation significantly sooner as compared to controls (Fig. 4d, currents. Bottom, I/V curve of Ca 2+ current from AN (black) and AA (gray) neurons (AN, n = 12; AA, n = 9). 4-AP 4-aminopyridine, TEA tetraethylammonium, TTX tetrodotoxin rheobase, threshold, maximum, amplitude, latency, and half width (Fig. 4e-g ). Although these parameters were not significantly different in both groups, autistic patient iPSC-derived neurons showed a trend of more excitability as shown by the parameters of action potential number, rheobase, threshold, and latency (Fig. 4c, f, and g ).
To confirm neuronal identity and maturity of the cells, we recorded main known neuronal voltage-gated currents: Na + , K + , and Ca
2+
. All of these currents were present in autistic patient and control iPSC-derived neurons (Fig. 4h-j) . No differences were observed in either Ca 2+ or slow inactivating K + (also known as D-type) voltage-gated currents (Fig. 4h, j) . However, significant decreases in both Na + and fast inactivating K + (also known as A-type) voltage-gated currents were observed in autistic patient iPSC-derived neurons (Fig. 4h, i) .
Differentially Expressed Genes in Autistic Patient iPSC-Derived Neurons Revealed Core Pathways in Synaptic Transmission
Principal component analysis (PCA) for global gene expression of iPSC-derived neurons revealed that samples from autistic patients cluster together and are separate from their unaffected sib controls (Fig. 5a ). We identified differentially expressed genes between iPSC-derived neurons from autistic patients as compared to their unaffected siblings (Fig. 5b) . In total, 161 unique genes (109 up-regulated and 52 down-regulated) showed greater than twofold-expression changes between autistic patient and control iPSC-derived neurons with a FDR less than 0.05 via microarray (Fig. 5b and Supplementary file 1: Table S2 ). We confirmed a subset of these genes via quantitative PCR (Supplementary file 1: Table S3 ). Twenty-two genes (14 %) with altered expression in autistic patient iPSC-derived neurons have previously been implicated in ASD (Fig. 5c ) and annotated in the SFARI Gene Database (https://gene.sfari.org) [8] , including many with strong association to ASD such as cadherin 10 (CDH10), neurexin 3 (NRXN3), synapsin III (SYN3), dipeptidyl peptidase 10 (DPP10), gamma-aminobutyric acid (GABA) A receptor alpha 3 (GABRA3), and voltage-gated Na + type II alpha subunit (SCN2A) (Fig. 5c) . This enrichment for known ASD candidate genes was highly significant (p = 2.21 × 10 −9 ) (Fig. 5c) . Additionally, gene ontology (GO) analysis of these 22 differentially expressed genes previously implicated in ASD revealed a number of significant pathways (p < 0.05) related to synaptic function (synapse, postsynaptic membrane, synaptic transmission, synaptogenesis, and integrin signaling), neurotransmitter function (neurotransmitter receptor activity, neurotransmitter secretion/ binding), and ion channels function (extracellular ligandgated ion channel activity, GABA-A receptor activity) (Supplementary file 1: Table S4 ).
GO analysis of all 161 differentially expressed genes identified significant enrichment of processes related to nervous system development, transmission of nerve impulse as well as mechanisms of synapse formation such as GABAergic synapse pathway, PI3K-Akt signaling, neuroactive ligand-receptor interaction, and extracellular matrix (ECM)-receptor interaction (Table 2 ). The 161 differentially expressed genes were analyzed for gene interaction networks using the Ingenuity Pathway Analysis (IPA) database. Several significant interaction networks were identified, with central nodes that support the GO enrichment results, such as ERK1/2, integrin, insulin, GABA receptors, matrix metallopeptidase 9 (MMP9), cAMP responsive element binding protein (CREB), PI3K-Akt signaling, and ubiquitin C (Table 3 ; see Supplementary file 1:
Figs. S7-S9 for IPA network illustrations). Moreover, the predicted upstream fundamental regulators of these networks include canonical signaling molecules such as catenin (cadherin-associated protein) beta 1 (CTNNB1), GABA-A receptor alpha 1 (GABRA1), RE1-silencing transcription factor (REST), and huntingtin (HTT) (Fig. 5d) . Top-ranked gene interaction networks were enriched for the IPA terms Bnervous system development and function,^Bhereditary disorder,B psychological disorders,^Bneurological disease,^Bnutri-tional disease,^Bbehavioral disorders,^Bdevelopmental disorder,^and Bophthalmic disease^ (Table 3) . These results raised our interest to explore the overlap of the differentially expressed genes in our autistic patient iPSC-derived neurons with genes previously implicated in other psychiatric disorders, as the genetics underlying various psychiatric disorders have been shown to be overlapping [27] . Gene-disorder association analysis from Autworks database (http://autworks. hms.harvard.edu) [28] showed the 161 differentially expressed genes in autistic patient iPSC-derived neurons were significantly associated with childhood schizophrenia, epilepsy, neurotic disorders, and autistic disorder (p < 0.05) ( Table 2 ). This is particularly intriguing given the significant co-morbidity of these disorders in autistic patients.
Discussion
As more and more evidence accumulated, it was well accepted that autistic behaviors resulted from dysregulated brain development [29] , altered brain structure [30] , and functional connectivity [10, 11, 31] , and Ba disease of abnormalities in synaptic transmission of neurons^becomes the major hypothesis for the cellular basis of ASD [12] . Despite this hypothesis has gained indirect support from human post-mortem brain examination, animal models, and genetic studies [12, 32, 33] , little is known about the pathophysiology of live patient neurons. Using human iPSC-derived neurons to model brain networks has great potential to improve our understanding of humanspecific neurodevelopmental disorders such as ASD. Here, we demonstrate that iPSC-derived functional neurons provide important insights of idiopathic forms of ASD at both the cellular and genomic levels. We identified 161 differentially expressed genes in autistic patient iPSC-derived neurons as compared to unaffected siblings, which were enriched for ion channels and synaptic functions. These results, together with cellular-level analysis demonstrating aberrant voltage-gated currents and globally altered neural networks in the autistic patient iPSC-neuron cultures, suggest the iPSC strategy can be effectively utilized to model idiopathic forms of ASD.
Thus, iPSC-derived neurons from idiopathic forms of ASD patients appear to recapitulate the elements of the disorder contributed by complex genetic components, potentially serving as a valuable model for further investigation of idiopathic forms of ASD. A number of previous studies have investigated syndromic or single-gene causes of ASD using iPSC-derived neurons. It has been documented that iPSC-derived neurons display cellular phenotypes such as abnormal synaptic transmission for ASDs with known gene mutations (MECP2, CACNA1C, Akt A serine/threonine-specific protein kinase, also known as protein kinase B; ECM extracellular matrix; PI3K phosphatidylinositol-4,5-bisphosphate 3-kinase, now known as PIK3CA a Source of analysis: Partek Genomics Suite; DAVID Bio-informational database; Ingenuity Pathway Analysis database; Autworks Gene-disease association analysis SHANK3) [20, [34] [35] [36] or chromosomal abnormalities (15q11-q13, 22q13.3) [37] [38] [39] as well as for a nonsyndromic ASD case with de novo balanced translocation disruption of TRPC6 [40] . For instance, iPSC-derived neurons generated from children with Rett syndrome have smaller soma size, fewer synapses, reduced spine density, altered calcium signaling, and electrophysiological defects [20] -cellular characteristics similar to those observed in post-mortem Rett syndrome brains [41] and animal models [42] . iPSC-derived neurons from patients with SHANK3 mutations, a rare but highly penetrant ASD-associated variant, were reported to have excitatory neuron dysfunction [38] . Moreover, a recent study using iPSC-derived neurons from a non-syndromic ASD case caused by de novo translocation of TRPC6 demonstrated that Na + currents of TRPC6-mutated neurons were impaired as compared to controls [40] . Our iPSC-derived neurons from idiopathic forms of ASD patients replicate some of these findings from syndromic ASD. For example, the electrophysiological properties of these ASD patient iPSC-derived neural cultures showed significant decreases in the frequency of sEPSC relative to controls, suggesting a presynaptic impairment in synaptic transmission [26] and that the global neuronal network is altered in autistic patient iPSC-derived neuron cultures [20] .
In addition, our electrophysiological results also provide new observation on cellular phenotypes of ASD patient iPSC-derived neurons. Genetic studies have previously linked the role of ion channel genes defects in the pathogenesis of ASD like alternation of brain excitability [43] [44] [45] . However, little is known about the ion channel function of live patient neurons. Our electrophysiological results of ASD patient iPSC-derived neural cultures showed significant decreases in both Na + and fast K + voltage-gated currents, but not in Ca
2+
and slow K + voltage-gated currents. The reduction of Na + and fast K + voltage-gated currents likely accounts for the observation that autistic patient iPSC-derived neurons have altered excitability since these two currents greatly impact action potential firing properties [44] . Meanwhile, our gene expression results of patient iPSC-derived neurons also suggested ion channel defects could be cellular phenotypes associated with ASD. We found that there is a differential expression of genes of sodium and potassium channels and their subunits in ASD patient iPSC-derived neurons, including voltage-regulated sodium channel type 2 SCN2A and potassium voltage-gated channel (A-channel) KCND2. Through applying neural morphological and electrophysiological analysis on live neurons derived from patient-specific iPSCs, we may gain alternative evidences to study pathogenesis of ASD, in addition to indirect support from human post-mortem brain examination, animal models, and genetic studies. In addition to recapitulating the cellular-level findings of previous studies of autistic patient iPSC-derived neurons, our results also demonstrated the iPSC-neurons from idiopathic forms of ASD patients retain gene expression signatures relevant to previously identified ASD candidate genes and molecular pathways. For instance, the differentially expressed genes in autistic patient iPSC-neurons compared to their unaffected siblings were significantly enriched for genes previously implicated in ASD, such as CDH10, DPP10, GABAR3, NRXN3, SCN2A, and SYN3. Defects of voltage-gated K + channels (Kv) have been correlated with ASD [45] . Both DPP6 and DPP10 are A-type Kv4 subunits. DPP6 has been shown to be responsible for enhanced A-type K + currents in adult hippocampal CA1 pyramidal neuron dendrites [46] , thus, mis-expression of DPP10 may account for the decrease in A-type K + currents we observed in this study. Interestingly, most of these 22 overlapping genes (20/22 genes) have been identified as de novo variants or CNVs, supporting the increasing observation of de novo mutations and CNVs in patients with idiopathic ASD [5, [47] [48] [49] , and underscoring the importance of developing cellular models that retain the unique genetic features of patients with idiopathic ASD. In addition, in a recent transcriptome analysis of post-mortem autistic brains, researchers identified 444 differentially expressed genes in ASD cortex tissues (n = 29) when comparing to control cortex tissues (n = 29) [50] . There is a significant (p = 8.12 × 10 −9
) overlap of 18 genes between 161 differentially expressed genes in autistic patient iPSC-derived neurons and 444 differentially expressed genes in ASD cortex post-mortem tissues (Supplementary file 1: Fig. S10 ). Furthermore, while the remainder of differentially expressed genes have not been previously implicated in ASD, many belong to pathways that have been strongly linked to ASD pathogenesis. For example, GABAergic dysfunction has been repeatedly implicated in ASD with the GABA receptor GABRB3, perhaps the most significantly associated GABA-related gene [51] , yet we also observed significant mis-expression of other GABA receptors such as GABRB1, GABRA2, GABRQ, and GABRG2. Moreover, based on the top-rated gene networks, IPA predicted several upstream or fundamental regulators for our 161 genes, such as CTNNB1 and GABRA1. CTNNB1, also known as β-catenin, have recently been identified as one of the top de novo ASD risk contributing mutations [48] . GABRA1 encodes the α1 subunit of GABA-A receptor. As discussed above, several subunits of GABA-A receptor have been linked to ASD, such as GABRA4, GABRB1, and GABRB3 [51] , indicating the importance role of GABA-A receptor family. These gene expression results suggest that iPSC-derived neurons from idiopathic forms of ASD patients maintain the functional genomic properties of idiopathic ASD neural tissue with a fidelity that makes them a great in vitro model. Additionally, our assessment of molecular pathways and genetic interaction networks among the differentially expressed genes lends further support that iPSC-neurons derived from idiopathic forms of ASD patients recapitulate the cellular and molecular phenotypes previously associated with ASD. We discovered that the identified differentially expressed genes were highly enriched for pathways related to synaptic structure/activity and ion channel function, which is particularly intriguing given that we identified aberrant voltage-gated ion channel currents in the electrophysiology studies. This additional level of support is particularly important in the context of idiopathic forms of ASD, as there is increasing evidence that the hundreds of genes identified thus far in ASD may ultimately relate to a few signaling networks and/or molecular pathways that underlie the broad ASD phenotype [50, 52] .
Finally, gene-disorder association analysis (Autworks) indicated that differentially expressed genes identified in the autistic patient iPSC-neurons were significantly associated not just with ASD but also with childhood schizophrenia, epilepsy, ADHD, and bipolar disorder. These results are in agreement with the well-known overlap of ASD candidate genes with genes previously implicated in these other neurodevelopmental disorders [7] , and the blurring diagnostic and genetic boundaries among the common neurodevelopmental disorders [53] .
In summary, we demonstrate here that iPSC-derived neurons generated from patients with ASD as compared to unaffected siblings have aberrant cellular and molecular phenotypes that recapitulate previous iPSC studies of syndromic ASD and single gene animal models, and relate to known genetic risk factors for ASD. To further uncover the underlying molecular and cellular basis of idiopathic forms of ASD, approaches such as iPSCderived neurons will be an important method to obtain tissue for study that appropriately recapitulates the complex dynamics of an autistic patient neural cell. Our results suggest such an approach is feasible and will provide unique insight into cellular and molecular underpinnings of ASD, especially when coupled with robust clinical and phenotypic patient data.
